Iron-silicate-coated porous silicon nanoparticles for in situ ROS self-generation
Source abstract
Abstract
Porous silicon nanoparticles (pSiNPs) have gained attention from drug delivery systems (DDS) due to their biocompatibility, high drug-loading efficiency, and facile surface modification. To date, many surface chemistries of pSiNPs have been developed to maximize the merits and overcome the drawbacks of pSiNPs. In this work, we newly disclosed a formulation, iron-silicate-coated pSiNPs (Fe-pSiNPs-NCS), using the surface modification method with iron-silicate and 3-isothiocyanatopropyltriethoxysilane (TEPITC). Fe-pSiNPs-NCS demonstrated effective reactive-oxygen species (ROS) self-generation ability via a Fenton-like reaction of iron-silicate and in situ hydrogen peroxide (H2O2) generation of TEPITC on the surface of pSiNPs, resulting in excellent anticancer effect in U87MG cancer cells. Moreover, we confirmed that Fe-pSiNPs-NCS could be used as a drug delivery carrier as it was proven that anticancer drugs (doxorubicin, SN-38) were loaded into Fe-pSiNPs-NCS with high-loading efficiency. These findings could offer efficient strategies for developing nanotherapeutics in biomedical fields.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silicon Nanostructures and Photoluminescence · Advanced Nanomaterials in Catalysis · Nanowire Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Tailoring porous silicon for biomedical applications: from drug delivery to cancer immunotherapy10.1002/adma.201703740 ↗
2. Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody10.1002/adma.201200776 ↗
3. Gadolinium silicate-coated porous silicon nanoparticles as an MRI contrast agent and drug delivery carrier10.1016/j.matchemphys.2022.126345 ↗
4. A mini review: recent advances in surface modification of porous silicon10.3390/ma11122557 ↗
5. Biocompatibility assessment of Si-based nano-and micro-particles10.1016/j.addr.2012.05.008 ↗
6. Thermally carbonized porous silicon and its recent applications10.1002/adma.201703819 ↗
7. Degradability and clearance of silicon, organosilica, silsesquioxane, silica mixed oxide, and mesoporous silica nanoparticles10.1002/adma.201604634 ↗
8. Biomaterial-based delivery of nucleic acids for tissue regeneration10.1016/j.addr.2021.113885 ↗
9. A review of small molecules and drug delivery applications using gold and iron nanoparticles10.2147/IJN.S184723 ↗
10. Protein delivery into cells using inorganic nanoparticle–protein supramolecular assemblies10.1039/C8CS00008E ↗
11. A copper-loaded N-doped carbon catalyst with mesoporous hollow sphere structure for bisphenol A removing via peroxymonosulfate activation10.1016/j.micromeso.2022.112133 ↗
12. Fluorescent detectors for hydroxyl radical and their applications in bioimaging: a review10.1016/j.ccr.2020.213457 ↗
13. Redox metabolism: ROS as specific molecular regulators of cell signaling and function10.1016/j.molcel.2021.08.018 ↗
14. ROS-responsive hollow mesoporous silica nanoparticles loaded with Glabridin for anti-pigmentation properties10.1016/j.micromeso.2021.111429 ↗
15. ROS in cancer therapy: The bright side of the moon10.1038/s12276-020-0384-2 ↗
16. ROS-modulated therapeutic approaches in cancer treatment10.1007/s00432-017-2464-9 ↗
17. Novel insights on targeting ferroptosis in cancer therapy10.1186/s40364-020-00229-w ↗
18. Enhanced cisplatin chemotherapy by iron oxide nanocarrier-mediated generation of highly toxic reactive oxygen species10.1021/acs.nanolett.6b04269 ↗
19. Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes10.1016/j.jhazmat.2014.04.054 ↗
20. Oxidative stress in cancer10.1016/j.ccell.2020.06.001 ↗
21. Sanguinarine attenuates hydrogen peroxide-induced toxicity in liver of Monopterus albus: Role of oxidative stress, inflammation and apoptosis10.1016/j.fsi.2022.05.013 ↗
22. Role of glutathione in cancer progression and chemoresistance10.1155/2013/972913 ↗
23. Self-activating therapeutic nanoparticle: a targeted tumor therapy using reactive oxygen species self-generation and switch-on drug release10.1021/acsami.1c07037 ↗
24. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate10.1016/j.ccr.2006.08.009 ↗
25. Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates10.1093/carcin/22.3.425 ↗
26. Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells10.1093/carcin/21.6.1175 ↗
27. Unraveling the potential role of glutathione in multiple forms of cell death in cancer therapy
28. A review of classic Fenton’s peroxidation as an advanced oxidation technique10.1016/S0304-3894(02)00282-0 ↗
29. Chemical stability of porous silicon surfaces electrochemically modified with functional alkyl species10.1021/la035197y ↗
30. Size control of porous silicon nanoparticles by electrochemical perforation etching10.1002/ppsc.201300244 ↗
31. Glioblastoma homing photodynamic therapy based on multifunctionalized porous silicon nanoparticles10.1021/acsanm.2c00368 ↗
32. Synthesis, bioactivity and mechanical stability of Mg/Ca silicate biocomposites developed for tissue engineering applications10.1002/slct.201902780 ↗
33. Biofabrication of iron oxide nanoparticles as a potential photocatalyst for dye degradation with antimicrobial activity10.1007/s13762-019-02402-7 ↗
34. Analysis of XPS spectra of Fe2+ and Fe3+ ions in oxide materials10.1016/j.apsusc.2007.09.063 ↗
35. Surface modification of iron oxide (Fe2O3) pigment particles with amino-functional polysiloxane for improved dispersion stability and hydrophobicity10.1108/PRT-07-2013-0057 ↗
36. Silver nanoparticles functionalized by fluorescein isothiocyanate or rhodamine b isothiocyanate: fluorescent and plasmonic materials10.3390/app11062472 ↗
37. Formation of a silicato-iron (III) complex in dilute aqueous solution10.1016/0022-1902(65)80215-9 ↗
38. Self-assembled copper–amino acid nanoparticles for in situ glutathione “AND” H2O2 sequentially triggered chemodynamic therapy10.1021/jacs.8b08714 ↗
39. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity10.1021/ja104683w ↗
40. A comparative study on oxidation of acidic red 18 by persulfate with ferrous and ferric ions10.3390/catal10060698 ↗
41. Dose and time effect of CdTe quantum dots on antioxidant capacities of the liver and kidneys in mice10.2147/IJN.S142008 ↗
42. The acid decomposition of silicate minerals part I. Reactivities and modes of dissolution of silicates10.1016/0304-386X(83)90002-6 ↗
43. Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2′, 7′–dichlorofluorescin diacetate (DCFDA) assay10.1016/j.vascn.2018.03.007 ↗
44. Biodegradable, hydrogen peroxide, and glutathione dual responsive nanoparticles for potential programmable paclitaxel release10.1021/jacs.7b12025 ↗